Alvogen Licensing Agreement (Details) - NRX-101 - License Agreement - Alvogen - USD ($) $ in Millions		6 Months Ended
Jun. 02, 2023	Jun. 30, 2023
Alvogen Licensing Agreement
Initial term		20 years
Renewal term		2 years
Equity royalty payable period in case of reversion license	30 days
First milestone payment to be received	$ 10
Second milestone payment receivable	5
Maximum bonus milestone payment receivable	$ 330

Initial cash payment to be received.

No definition available.

Name:	nrxp_InitialCashPaymentToBeReceived
Namespace Prefix:	nrxp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Term of license agreement from the first commercial sale of Product.

+ References

No definition available.

+ Details

Name:	nrxp_LicenseAgreementInitialTerm
Namespace Prefix:	nrxp_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of business days for payment of equitable royalty in case of reversion license.

+ References

No definition available.

+ Details

Name:	nrxp_LicenseAgreementMinimumPeriodForEquitableRoyaltyPayableInCaseOfReversionLicense
Namespace Prefix:	nrxp_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Renewal term of license agreement upon request made prior to the expiration of such initial term.

+ References

No definition available.

+ Details

Name:	nrxp_LicenseAgreementRenewalTerm
Namespace Prefix:	nrxp_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum bonus milestone payments receivable.

+ References

No definition available.

+ Details

Name:	nrxp_MaximumBonusMilestonePaymentsReceivable
Namespace Prefix:	nrxp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Second milestone payments receivable.

+ References

No definition available.

+ Details

Name:	nrxp_SecondMilestonePaymentsReceivable
Namespace Prefix:	nrxp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_ProductOrServiceAxis=nrxp_TherapeuticProductNrx101Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=nrxp_ExclusiveGlobalDevelopmentSupplyMarketingLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=nrxp_AlvogenPharmaUsInc.AlvogenInc.AndLotusPharmaceuticalCo.LtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: